Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure

British Journal of Cancer

Volumn 88, Issue 9, 2003, Pages 1400-1402

  Tonetti, D A ^a   Morrow, M ^b   Kidwai, N ^b   Gupta, A ^b   Badve, S ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Breast cancer; Protein kinase C alpha; Tamoxifen resistance

Indexed keywords

PROTEIN KINASE C ALPHA; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER RECURRENCE; CANCER RESISTANCE; CLINICAL ARTICLE; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT FAILURE; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RECURRENCE; RETROSPECTIVE STUDIES; TAMOXIFEN; TREATMENT FAILURE;

EID: 0038146847     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600923     Document Type: Article

References (17)

1. 2+-dependent protein kinase of human mammary carcinoma cells: inverse relationship to estrogen receptors. Int J Cancer 40: 344-348
2. Brunner N, Spang-Thomsen M, Cullen K (1996) The T61 human breast cancer xenograft: an experimental model of estrogen therapy of breast cancer. Breast Cancer Res Treat 39: 87-92
3. Chisamore MJ, Ahmed Y, Bentrem DJ, Jordan VC, Tonetti DA (2001) Novel antitumor effect of estradiol in athymic mice injected with a T47d breast cancer cell line overexpressing protein kinase c alpha. Clin Cancer Res 7: 3156-3165
4. Dumont JA, Bitonti AJ, Wallace CD, Baumann RJ, Cashman EA, Cross-Doersen DE (1996) Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. Cell Growth Differ 7: 351-359
5. Fernandez P, Wilson C, Hoivik D, Safe SH (1998) Altered phenotypic characteristics of T47D human breast cancer cells after prolonged growth in estrogen-deficient medium. Cell Biol Int 22: 623-633
6. Gordge PC, Hulme MJ, Clegg RA, Miller WR (1996) Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer 32A: 2120-2126
7. Johnston SR, Lu B, Scott GK, Kushner PJ, Smith IE, Dowsett M, Benz CC (1999) Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. Clin Cancer Res 5: 251-256
8. Masamura S, Santner SJ, Heitjan DF, Santen RJ (1995) Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 80: 2918-2925
9. O'Brian C, Vogel VG, Singletary SE, Ward NE (1989) Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 49: 3215-3217
10. Peethambaram PP, Ingle JN, Suman VJ, Hartmann LC, Loprinzi CL (1999) Randomized trial of diethylstilbestrol vs tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Res Treat 54: 117-122
11. Schiff R, Reddy P, Ahotupa M, Coronado-Heinsohn E, Grim M, Hilsenbeck SG, Lawrence R, Deneke S, Herrera R, Chamness GC, Fuqua SA, Brown PH, Osborne CK (2000) Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J Natl Cancer Inst 92: 1926-1934
12. Shim WS, Conaway M, Masamura S, Yue W, Wang JP, Kmar R, Santen RJ (2000) Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo. Endocrinology 141: 396-405
13. Song R, McPherson R, Yue W, Wang J, Santen R (2000) Estrogen induces apoptosis in human breast cancer cells adapted to long term estrogen deprivation. In American Association for Cancer Research Vol. 41, pp 427 San Francisco, CA
14. Song RX, Mor G, Naftolin F, McPherson RA, Song J, Zhang Z, Yue W, Wang J, Santen RJ (2001) Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol. J Natl Cancer Inst 93: 1714-1723
15. Sonnenschein C, Szelei J, Nye TL, Soto AM (1994) Control of cell proliferation of human breast MCF7 cells; serum and estrogen resistant variants. Oncol Res 6: 373-381
16. Tonetti DA, Chisamore MJ, Grdina W, Schurz H, Jordan VC (2000) Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines. Br J Cancer 83: 782-791. doi:10:1054/ bjoc.2000.1326
17. Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC (2000) Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Clin Cancer Res 6: 2028-2036